| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Effect of Essential Oils on Pathogenic Bacteria | Pharmaceuticals | 2013 | 1,349 |
| 2 | The Therapeutic Potential of Naringenin: A Review of Clinical Trials | Pharmaceuticals | 2019 | 523 |
| 3 | Essential Oils and Antifungal Activity | Pharmaceuticals | 2017 | 449 |
| 4 | Human Antimicrobial Peptides and Proteins | Pharmaceuticals | 2014 | 417 |
| 5 | Antimicrobial Peptides from Plants | Pharmaceuticals | 2015 | 378 |
| 6 | Improving the Endosomal Escape of Cell-Penetrating Peptides and Their Cargos: Strategies and Challenges | Pharmaceuticals | 2012 | 331 |
| 7 | Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer | Pharmaceuticals | 2014 | 326 |
| 8 | Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth | Pharmaceuticals | 2019 | 318 |
| 9 | Clinical Toxicities of Histone Deacetylase Inhibitors | Pharmaceuticals | 2010 | 292 |
| 10 | Methods of Synthesis, Properties and Biomedical Applications of CuO Nanoparticles | Pharmaceuticals | 2016 | 288 |
| 11 | Antimicrobial Peptides Targeting Gram-Positive Bacteria | Pharmaceuticals | 2016 | 287 |
| 12 | Advances in Mammalian Cell Line Development Technologies for Recombinant Protein Production | Pharmaceuticals | 2013 | 265 |
| 13 | Cell-Penetrating Peptides—Mechanisms of Cellular Uptake and Generation of Delivery Systems | Pharmaceuticals | 2010 | 264 |
| 14 | Antimicrobial Peptides from Fish | Pharmaceuticals | 2014 | 260 |
| 15 | Cobalt Complexes as Antiviral and Antibacterial Agents | Pharmaceuticals | 2010 | 251 |
| 16 | Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy | Pharmaceuticals | 2019 | 248 |
| 17 | Old Drugs as New Treatments for Neurodegenerative Diseases | Pharmaceuticals | 2018 | 238 |
| 18 | Antibody–Drug Conjugates: The Last Decade | Pharmaceuticals | 2020 | 235 |
| 19 | Glioblastoma Multiforme Therapy and Mechanisms of Resistance | Pharmaceuticals | 2013 | 231 |
| 20 | The Treatment of Impaired Wound Healing in Diabetes: Looking among Old Drugs | Pharmaceuticals | 2020 | 214 |
| 21 | Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy | Pharmaceuticals | 2010 | 212 |
| 22 | Roles of Heat Shock Proteins in Apoptosis, Oxidative Stress, Human Inflammatory Diseases, and Cancer | Pharmaceuticals | 2018 | 209 |
| 23 | Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review | Pharmaceuticals | 2020 | 209 |
| 24 | A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011 | Pharmaceuticals | 2013 | 205 |
| 25 | Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics | Pharmaceuticals | 2013 | 204 |
| 26 | Gut Microbiota and Iron: The Crucial Actors in Health and Disease | Pharmaceuticals | 2018 | 203 |
| 27 | Heparin: Past, Present, and Future | Pharmaceuticals | 2016 | 202 |
| 28 | The Role of NCOA4-Mediated Ferritinophagy in Health and Disease | Pharmaceuticals | 2018 | 198 |
| 29 | Nonsteroidal Anti-Inflammatory Drugs and the Kidney | Pharmaceuticals | 2010 | 191 |
| 30 | Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders | Pharmaceuticals | 2018 | 187 |
| 31 | Peptides and Peptidomimetics for Antimicrobial Drug Design | Pharmaceuticals | 2015 | 185 |
| 32 | Inhaled Corticosteroids | Pharmaceuticals | 2010 | 184 |
| 33 | Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases | Pharmaceuticals | 2010 | 183 |
| 34 | FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver | Pharmaceuticals | 2013 | 181 |
| 35 | Curcumin, a Natural Antimicrobial Agent with Strain-Specific Activity | Pharmaceuticals | 2020 | 180 |
| 36 | The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments | Pharmaceuticals | 2010 | 176 |
| 37 | Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges | Pharmaceuticals | 2013 | 172 |
| 38 | Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress—Protective Activity | Pharmaceuticals | 2010 | 171 |
| 39 | Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications | Pharmaceuticals | 2018 | 171 |
| 40 | A Critical Review of Alpha Radionuclide Therapy—How to Deal with Recoiling Daughters? | Pharmaceuticals | 2015 | 170 |
| 41 | Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks | Pharmaceuticals | 2010 | 168 |
| 42 | Antimicrobial Peptides in 2014 | Pharmaceuticals | 2015 | 168 |
| 43 | Cannabidiol in Humans—The Quest for Therapeutic Targets | Pharmaceuticals | 2012 | 162 |
| 44 | Lactoferrin from Milk: Nutraceutical and Pharmacological Properties | Pharmaceuticals | 2016 | 156 |
| 45 | Role of Microglial M1/M2 Polarization in Relapse and Remission of Psychiatric Disorders and Diseases | Pharmaceuticals | 2014 | 154 |
| 46 | Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities | Pharmaceuticals | 2010 | 142 |
| 47 | Iron Regulation: Macrophages in Control | Pharmaceuticals | 2018 | 141 |
| 48 | Glycosaminoglycans and Proteoglycans | Pharmaceuticals | 2018 | 141 |
| 49 | Network Pharmacology Approach for Medicinal Plants: Review and Assessment | Pharmaceuticals | 2022 | 141 |
| 50 | Dendrimers for siRNA Delivery | Pharmaceuticals | 2013 | 139 |
